Sarah Eliuth Ochoa Hugo | Nanomedicine | Young Scientist Award

Published on by Top Pharmaceutical

Dr. Sarah Eliuth Ochoa Hugo | Nanomedicine | Young Scientist Award

Dr. Sarah Eliuth Ochoa Hugo at Center of Research and Assistance in Technology and Design of the State of Jalisco| Mexico

Dr. Sarah Eliuth Ochoa Hugo is a dedicated pharmaceutical chemist, biotechnologist, and researcher specializing in medical and pharmaceutical innovation. Currently pursuing her Ph.D. in Biotechnological Innovation Applied to Health at CIATEJ, she integrates her expertise in biotechnology, nanotechnology, and pharmacology to address critical challenges in cancer, Alzheimer’s disease, and medical device safety. As a lecturer at Universidad del Valle de México, she mentors future health professionals, guiding them in scientific research and publication. Alongside academia, she engages in entrepreneurial initiatives that merge scientific innovation with social impact, demonstrating her commitment to advancing healthcare through research, education, and applied technology.

Publication Profile 

Orcid

Education 

Dr. Sarah Eliuth Ochoa Hugo is currently a Ph.D. candidate in Biotechnological Innovation Applied to Health at CIATEJ, focusing on advanced biomedical solutions. She previously earned her Master of Science in Biotechnological Innovation Applied to Medical and Pharmaceutical Sciences at CIATEJ, where her thesis explored exosomal cargo in Alzheimer’s pathogenesis. Her academic foundation was built at Universidad del Valle de México, where she completed a Bachelor of Science in Pharmaceutical Chemistry and Biotechnology. There, she validated a 3D glioblastoma multiforme culture model. Complementing her degrees, she has completed certifications in pharmaceutical regulation, medical English, cancer biology, pharmacology, and advanced English proficiency.

Experience 

Dr. Sarah Eliuth Ochoa Hugo serves as an undergraduate lecturer in Health Sciences at Universidad del Valle de México, where she promotes research-oriented learning and student publications. She is co-founder of Quality Approvers, a startup advancing process optimization using Lean and Six Sigma methodologies. Previously, she worked as a Pharmaceutical Chemist and Assistant Sanitary Responsible at San Javier Hospital, ensuring pharmaceutical compliance and safety. During the pandemic, she launched Paihuenk, a social entrepreneurship project producing artisanal cosmetics to support local communities. With extensive academic and industry experience, she bridges biomedical research, pharmaceutical practice, and innovation-driven entrepreneurship in health and biotechnology.

Awards and Honors 

Dr. Sarah Eliuth Ochoa Hugo achievements are reflected through her strong academic and research portfolio, including international presentations at the Society for Neuroscience meetings in San Diego and publications in prominent journals. Her certification by COFEPRIS in pharmaceutical dispensing underscores her compliance with industry standards, while academic training from King’s College London, Monash University, and Johns Hopkins has expanded her global expertise. At Universidad del Valle de México, she has been recognized for her excellence in teaching, demonstrated. Her contributions to translational research and community-focused entrepreneurship highlight her growing academic influence.

Research Focus 

Dr. Sarah Eliuth Ochoa Hugo research focuses on cancer therapy, Alzheimer’s disease, and medical device vigilance through biotechnological innovation. She has explored 3D glioblastoma culture models, evaluated phenolic compounds for anticancer activity, and investigated exosomal cargo in Alzheimer’s disease. Her recent work integrates nanotechnology, particularly gold nanostructures, for photothermal therapies in colon cancer. Additionally, she contributes to medical device monitoring and pharmaceutical safety through technovigilance research. Her multidisciplinary approach combines molecular biology, pharmacology, and nanomedicine, aiming to design innovative therapies with clinical applications. By integrating biotechnology with applied health sciences, her work advances precision medicine, preventive care, and translational biomedical innovation.

Publication Top Notes

Hani Serag | Nanomedicine | Best Researcher Award

Published on by Top Pharmaceutical

Dr. Hani Serag | Nanomedicine | Best Researcher Award

Director, Division of Global Partnerships at University of Texas Medical Branch (UTMB) | United States

Dr. Hani Serag is a physician and public health specialist with extensive experience in health systems research, global health, and addressing health disparities. Currently serving as Director of the Division of Global Partnerships and Assistant Professor at the Department of Population Health and Health Disparities, University of Texas Medical Branch (UTMB), he leads multiple programs on chronic disease prevention, HIV screening, and global health diplomacy. With a strong history of academic, research, and policy leadership, Dr. Serag has collaborated with international organizations, academic institutions, and civil society networks to strengthen healthcare equity, health policy, and global partnerships.

Publication Profile 

Google Scholar

Education 

Dr. Hani Serag earned his MD (M.B., B.Ch) from the Faculty of Medicine, Ain Shams University, Cairo, Egypt. He holds a Master of Public Health (MPH) degree from the School of Public Health, University of Western Cape, South Africa, focusing on health systems research, monitoring and evaluation, health promotion, and primary healthcare. He further enhanced his expertise with advanced training in epidemiology, health care finance, biostatistics, and both quantitative and qualitative public health research methods through certificate programs at Erasmus University, Rotterdam, the Netherlands. His academic training integrates medicine, epidemiology, and public health with a global and systems-oriented perspective.

Experience 

Dr. Hani Serag has held key academic and leadership roles at UTMB, including Assistant Professor in Population Health and Endocrinology and Director of Global Partnerships. He has served as Principal Investigator for programs on chronic disease prevention, HIV screening, and international educational collaborations. His professional record includes consultancy and teaching engagements with the Pan American Health Organization (PAHO) and the World Health Organization (WHO). He previously served as Global Coordinator and Associate Global Coordinator for the People’s Health Movement, leading international initiatives on primary healthcare, social determinants of health, and global health governance. His work bridges academia, policy, and practice.

Awards and Honors 

Dr. Hani Serag contributions have been recognized through academic appointments across diverse disciplines including population health, internal medicine, pediatrics, and global health. His role as an Associate Member of the Graduate Faculty at UTMB highlights his mentorship of graduate students. He has been invited by WHO and PAHO for technical consultancies, curriculum development, and training programs, reflecting his international recognition in health systems and migration health research. Through his leadership in convening UTMB’s Annual Conference on Migration and Health and directing global health education initiatives, Dr. Serag has earned respect as a distinguished public health leader advancing health equity worldwide.

Research Focus 

Dr. Hani Serag research focuses on advancing health system responsiveness, reducing disparities, and integrating preventive care into clinical settings. His work emphasizes chronic disease prevention, HIV screening, and global health governance. He has designed and implemented multi-stakeholder programs that address the social determinants of health and promote patient-centered models of care. His scholarly contributions include health policy research, health systems evaluation, and migration and health studies. He has actively developed curricula, technical reports, and peer-reviewed publications to build capacity in health equity and health policy. His ongoing research strengthens global partnerships and evidence-based strategies in population health.

Publication Top Notes

Covid-19 pandemic and the social determinants of health

Explaining covid-19 performance: what factors might predict national responses?

High‐protein vs. standard‐protein diets in overweight and obese patients with heart failure and diabetes mellitus: findings of the Pro‐HEART trial

Improving the collection of race, ethnicity, and language data to reduce healthcare disparities: a case study from an academic medical center

Cultural diversity impacts caregiving experiences: a comprehensive exploration of differences in caregiver burdens, needs, and outcomes

Racial and geographic variation in leg amputations among Texans

Relative social standing and suicide ideation among Kenyan males: the interpersonal theory of suicide in context

Racial disparities in type of heart failure and hospitalization

Social determinants of health in countries in conflict and crises: the eastern Mediterranean perspective

Subjective social standing and conflict tactics among young Kenyan men

Illustrating the impact of commercial determinants of health on the global COVID-19 pandemic: Thematic analysis of 16 country case studies

Enabling structural resilience of street-involved children and youth in Kenya: reintegration outcomes and the Flourishing Community model

Understanding caregiver challenges: A comprehensive exploration of available resources to alleviate caregiving burdens

Coronavirus disease 2019, diabetes, and inflammation: A systemic review

Exploring the impact of ACA on rural‐urban disparity in oral health services among US noninstitutionalized adults

The association between mental well-being and school attendance among Palestinian adolescent refugees in UNRWA schools

Nan Jiang | Nanomedicine | Best Researcher Award

Published on by Top Pharmaceutical

Nan Jiang | Nanomedicine | Best Researcher Award

Dr. Nan Jiang, Peking University School and Hospital of Stomatology, China

Dr. Nan Jiang is a distinguished biomedical researcher with a Ph.D. from Peking University (2015) and training from Columbia University and NYU School of Medicine. 🧠🦷 Her pioneering research focuses on craniofacial development, aging, and regeneration, especially through nanomedicine and exosome technologies. 🚀🧪 She has published over 35 peer-reviewed articles and authored a book on stem cells in craniofacial regeneration 📘. With an H-index of 16 📊 and a U.S. patent on exosome-based diagnostics, Dr. Jiang is shaping the future of regenerative dentistry and tissue engineering. 🌟🧫 Her innovative work continues to impact both science and clinical practice.

Publication Profile

Scopus

Education

Dr. Nan Jiang earned her Ph.D. in 2015 from Peking University 🎓, enriched by joint training at Columbia University 🇺🇸 and a visiting scholarship at NYU School of Medicine in 2017 🏥. Her research journey is rooted in the developmental biology of craniofacial organs, exploring mechanisms of aging and regeneration 🦷⏳. She is a pioneer in unveiling how nanomedicine can modulate the bone microenvironment 🔍💊. Through interdisciplinary approaches combining stem cell science, exosomes, and tissue engineering, Dr. Jiang continues to contribute groundbreaking insights to regenerative medicine and biomedical innovation.

Professional Memberships

Dr. Nan Jiang is an active member of the International Association for Dental Research (IADR) 🌍🦷, a globally respected organization that fosters excellence in oral health research. Through her membership, she collaborates with a diverse network of scientists and clinicians, advancing the frontiers of dental and craniofacial research 🔬🤝. Her involvement in IADR provides her with valuable opportunities to share her innovative work on nanomedicine, exosomes, and tissue regeneration at international forums 🌐📢. This professional affiliation strengthens her mission to translate scientific discoveries into real-world therapeutic solutions for oral health and beyond 🧪💡.

Research Focus

Dr. Nan Jiang’s research focus lies at the intersection of regenerative medicine, craniofacial biology, and nanotechnology 🧬🧫. She is particularly recognized for her work in regenerative endodontics, leveraging exosomes, stem cells, and nanomedicine to repair and regenerate dental tissues such as the pulp-dentin complex 🦷💉. Her studies also explore osteogenesis, oral tissue aging, and bone microenvironment modulation, with a special interest in single-cell RNA sequencing for understanding tooth development at a molecular level 🧠🔍. Her multidisciplinary approach is redefining future clinical practices in oral and maxillofacial regenerative therapies 🚀🏥.

Publication Top Notes

Regenerative endodontic therapy: From laboratory bench to clinical practice

Correction: Exosomes derived from human exfoliated deciduous teeth ameliorate adult bone loss in mice through promoting osteogenesis (Journal of Molecular Histology, (2020), 51, 4, (455-466), 10.1007/s10735-020-09896-3)

Advances in tooth development studies based on single-cell RNA sequencing

Jameel Al-Tamimi | Biopharmaceutics | Best Researcher Award

Published on by Top Pharmaceutical

Jameel Al-Tamimi | Biopharmaceutics | Best Researcher Award

Dr. Jameel Al-Tamimi, King Saud University, Saudi Arabia

Dr. Jameel Al-Tamimi is a distinguished researcher with a Ph.D. in Immunogenetics from King Saud University, Riyadh, Saudi Arabia. His research focuses on immunology, particularly the role of Killer Immunoglobulin-like Receptors (KIRs) in leukemia. He has expertise in molecular techniques, immunology, and forensic entomology. Dr. Al-Tamimi has published numerous research articles and has contributed to various academic committees. His teaching experience spans courses in molecular biology, human physiology, and medical entomology.

Publication Profile

Google Scholar

Education

Dr. Jameel Al-Tamimi 🎓 is a distinguished researcher with a Ph.D. in Immunogenetics (Excellent 4.9/5) from King Saud University, where his thesis explored the Role of Killer Immunoglobulin-like Receptors (KIRs) with HLA Ligands in Saudi Leukemia Patients 🧬. He also holds an M.Sc. in Entomology and Parasitology (Excellent 4.9/5), investigating the anti-inflammatory effects of Pachycondyla sennaarensis (Samsum Ant) venom in male albino rats 🐜🧪. Dr. Al-Tamimi earned his B.Sc. in Biology (Very Good 89.9/100) from Thamar University, Yemen, with research focused on physiological changes in viral hepatitis (HbsAg and HCV) patients at Thamar Hospital 🧫🦠.

Experience

Dr. Jameel Al-Tamimi 🧑‍🔬 brings a wealth of academic and research experience. Since 2023, he has served on the Scientific Committee for the Researcher Support Program (RSPD) and Research Groups Program (RGP) at the Deanship of Scientific Research 📚. At King Saud University, he contributed to key committees, including labs, academic accreditation, exams, and graduate studies 🏛️. He supervised both the endocrinology and immunology laboratories 🧪 and mentored undergraduate and master’s students 🎓. Skilled in handling rats, mice, and insects 🐭🦗, Dr. Al-Tamimi is also proficient in advanced molecular biology, immunology, and physiology techniques 🧬🔬.

Awards

Dr. Jameel Al-Tamimi 🎓 has been recognized for his academic excellence with several prestigious awards. In 2015, he received an acknowledgment certificate from the Chairman of the Center of Excellence in the Development of Science and Mathematics Education at King Saud University 🏅, highlighting his contribution to scientific advancement. Earlier, in 2013, he was honored with a Certificate of Appreciation (General Prize) during the first Graduate Student Annual Scientific Meeting at KSU 📜🎉. These achievements reflect his dedication to academic excellence, innovation in research, and commitment to the scientific community 🌟📚.

Research Focus

Dr. Jameel Al-Tamimi is a multidisciplinary biomedical researcher whose primary focus lies in oxidative stress, wound healing, diabetes, and nanoparticle therapeutics. His work spans nanomedicine, immunomodulation, and natural product pharmacology, particularly in evaluating the biological activities of camel milk peptides, selenium and zinc oxide nanoparticles, and bioactive plant extracts. Dr. Al-Tamimi’s studies contribute significantly to redox biology, diabetic complications, and biofabrication of therapeutic agents, offering innovative strategies for combating chronic diseases and enhancing healing processes. 🧫💊🐫 His collaborative work reflects a strong emphasis on toxicology, regenerative medicine, and bio-nanotechnology.

Publication Top Notes

Camel milk peptide improves wound healing in diabetic rats by orchestrating the redox status and immune response

Wound healing of different molecular weight of hyaluronan; in-vivo study‏

Folic acid and melatonin mitigate diabetic nephropathy in rats via inhibition of oxidative stress‏

Synthesis, structural characterization of silver (I)-NHC complexes and their antimicrobial, antioxidant and antitumor activities‏

Potential effects of the combination of nicotinamide, vitamin B2 and vitamin C on oxidative-mediated hepatotoxicity induced by thioacetamide‏

Efficacy of a Methanolic Extract of Adansonia digitata Leaf in Alleviating Hyperglycemia, Hyperlipidemia, and Oxidative Stress of Diabetic Rats‏

Antioxidant Bioactivity of Samsum Ant (Pachycondyla sennaarensis) Venom Protects against CCL4‐Induced Nephrotoxicity in Mice‏

Biofabrication of Zinc Oxide Nanoparticle from Ochradenus baccatus Leaves: Broad‐Spectrum Antibiofilm Activity, Protein Binding Studies, and In Vivo Toxicity …‏

jun ou | Nanomedicine | Best Academic Researcher Award

Published on by Top Pharmaceutical

jun ou | Nanomedicine | Best Academic Researcher Award

Prof. Dr. jun ou, Guilin University of Technology , China

Prof. Dr. Jun Ou is a renowned materials scientist specializing in biomaterials and nanotechnology. With a Ph.D. from Sichuan University, he serves as a professor at Guilin University of Technology. His expertise spans degradable bio-metals, upconversion nanomaterials, and smart drug delivery systems. He has served as a visiting scholar in Australia and Germany and has received multiple honors, including the Best Researcher Award 2023. Prof. Ou has published widely in high-impact journals and delivered talks at international conferences, contributing significantly to biomedical material innovation.

Publication Profile

Scopus

Education

Prof. Dr. Jun Ou is a distinguished academic with extensive qualifications in biomaterials and related fields. He earned his Ph.D. in Biomaterials from the University of Sichuan’s School of Materials Science and Engineering, where he studied from 2004 to 2010. Earlier, he completed his M.Sc. in Inorganic Chemistry at Guangxi Normal University between 2001 and 2003. His academic journey began with a Bachelor of Science in Engineering from the University of Science and Technology of Chengdu, where he studied from 1982 to 1986. His diverse academic background has laid a strong foundation for his contributions to the field of biomaterials.

Experience

Prof. Dr. Jun Ou has extensive teaching experience in Science and Engineering. From 2010 to 2022, he taught undergraduate and graduate courses at Guilin University of Technology, including “Introduction to Metallurgical Transmission Principles” and “Degradable Bio-Metal” focusing on novel ophthalmic materials. He designed course curricula, organized lectures, and graded assignments. As a professor, he has shared his expertise in Materials Science, Metallurgy, Physics, Inorganic Chemistry, Thermodynamics, and more, educating students worldwide. In addition, he has held visiting scholar positions, including at the Australian National University and Bundesanstalt für Materialforschung und-prüfung in Germany.

Awards

Prof. Dr. Jun Ou has received numerous prestigious awards and honors throughout his distinguished career. In 2023, he was honored with the Best Researcher Award at the International Research Awards on Advanced Nanomaterials and Nanotechnology. In 2022, he was named the Outstanding Open Science Author of the Year by Wiley-China. He also received the CSC Government of China Scholarship Council award in 2013 for his research project on rare earth nanomaterials and their application in constructing nano carbon monoxide carrier release systems, a three-year project that showcased his innovative contributions to nanotechnology and materials science.

Research Focus

Prof. Dr. Jun Ou is a prominent researcher in the field of luminescent materials and nanophosphors, with a specific focus on upconversion luminescence, optical temperature sensing, and lanthanide-doped materials. His work explores the design and enhancement of rare-earth-doped phosphors like NaYF₄: Yb, Ho and Er³⁺/Tm³⁺ systems for efficient green emission and thermometric applications. He also delves into nanoparticle-mediated nitric oxide delivery for biomedical applications like brain tumors. 🚀 His innovative use of Mn doping and 808 nm NIR excitation advances both materials science and nanomedicine, contributing significantly to next-gen optical sensors and bioimaging technologies.

Publication Top Notes

Synchronous realization of green upconversion emission enhancement and optical temperature sensitivity improvement in phosphors NaYF4: Yb, Ho via Mn doping

Promising lanthanide- NaYbF4:Er3+@NaYbF4:Tm3+ micro-phosphors for highly efficient upconversion luminescence and temperature sensing

Preliminary investigation of nitric oxide release from upconverted nanoparticles excited at 808 nm near-infrared for brain tumors

Corrigendum to “The synthesis of Er3+/Yb3+/K+ triple-doped NaYF4 phosphors and its high sensitivity optical thermometers at low power” J. Alloys Compd. 937 (March) (2023) 168299 (Journal of Alloys and Compounds (2023) 937, (S0925838822046904), (10.1016/j.jallcom.2022.168299))

Oliwia Kordyl | Drug Delivery Systems | Best Research Article Award

Published on by Top Pharmaceutical

Oliwia Kordyl | Drug Delivery Systems | Best Research Article Award

Ms. Oliwia Kordyl, Poznan Univeristy of Medical Sciences, Poland

Ms. Oliwia Kordyl (b. June 9, 1997) is a dedicated PhD student at Poznan University of Medical Sciences, specializing in 3D printed microneedles for targeted drug delivery. With a background in biotechnology from Adam Mickiewicz University, her work spans molecular biology, pharmaceutical technology, and reproductive genetics. Oliwia has held roles as a lab manager, molecular biologist, and biotechnologist, contributing to innovative projects and scientific conferences. She is skilled in advanced lab techniques and passionate about travel, fitness, and continuous learning.

Publication Profile

orcid

Education

Ms. Oliwia Kordyl is currently pursuing her Ph.D. (Nov 2023–Present) at the Poznan University of Medical Sciences in Poland, focusing on 3D printed microneedles for voriconazole delivery in treating local skin infections. Her research involves optimizing microneedle manufacturing, assessing physicochemical and pharmaceutical properties in vitro, and evaluating drug permeation ex vivo and microbiological effectiveness 🧪🧬. She earned her M.Sc. and B.Sc. in biotechnology from Adam Mickiewicz University (2016–2021), where she explored DNA methylation in oligozoospermia and gene expression in spermatogenesis 🧫. Her academic journey began at K.K. Baczyński Secondary School, specializing in biology, physics, and chemistry 🔬📚.

Experience

Ms. Oliwia Kordyl completed a valuable internship at Novazym Polska in Poznań from July to August 2019. During her time at this renowned biotechnology company, she gained hands-on experience in laboratory techniques and deepened her understanding of industrial biotechnology practices 🔬💼. The internship provided her with practical insights into the daily operations of a biotech firm and allowed her to apply her academic knowledge in a real-world setting 🧪📊. This experience not only enhanced her technical skills but also strengthened her passion for research and innovation in the field of biotechnology, laying a strong foundation for her future scientific endeavors 🚀.

Awards

🏆 Ms. Oliwia Kordyl has actively contributed to the scientific community through speeches and posters at esteemed conferences. She presented on sperm DNA methylation at the 21st Andrology Day (2019) 🧬 and the 21st European Testis Workshop (2021) in Barcelona. Her posters featured at ESHRE 2020, the European Human Genetics Conference (2021), and the 6th Polish Congress of Genetics (2022) showcased her expertise in epigenetics and sperm chromatin structure 🧫📊. In 2023, she co-authored a poster on microneedles for transdermal drug delivery at PolGerSym10 💉. Oliwia also co-authored a publication in the International Journal of Molecular Sciences (2022) 📄📚.

Research Focus

Ms. Oliwia Kordyl’s research focuses on the development of innovative drug delivery systems, particularly microneedle-based technologies for transdermal applications. Her work combines 3D printing, pharmaceutical coatings, and hydrogel systems to enhance the treatment of bacterial and fungal skin infections. She also explores photodynamic therapy and nanotechnology for targeted drug release. Her interdisciplinary approach bridges materials science, biomedical engineering, and pharmaceutics. Additionally, her research extends to epigenetic analysis in human sperm, highlighting her interest in reproductive biology. Her work is at the frontier of personalized medicine, non-invasive therapies, and advanced pharmaceutical technologies.

Publication Top Notes

Optimization of LCD-Based 3D Printing for the Development of Clotrimazole-Coated Microneedle Systems

Microneedle-based arrays – Breakthrough strategy for the treatment of bacterial and fungal skin infections

Microneedle System Coated with Hydrogels Containing Protoporphyrin IX for Potential Application in Pharmaceutical Technology

Global 5mC and 5hmC DNA Levels in Human Sperm Subpopulations with Differentially Protaminated Chromatin in Normo- and Oligoasthenozoospermic Males

ABDUL ABDUZ ZAHIR | Nanomedicine | Best Researcher Award

Published on by Top Pharmaceutical

ABDUL ABDUZ ZAHIR | Nanomedicine | Best Researcher Award

Dr. ABDUL ABDUZ ZAHIR, C. Abdul Hakeem College, Autonomous, India

Dr. ABDUL ABDUZ ZAHIR🎓 is a dedicated zoologist with a Ph.D. from Thiruvalluvar University (2015) and over 14 years of teaching experience. Passionate about research, he has published extensively, focusing on nanotechnology, antidiabetic drug encapsulation, and biolarvicidal compounds. 🦠 He has organized multiple national and international conferences, actively mentors students, and contributes to social causes. 🏅 His accolades include the Special Jury Award (2023) and university ranks. As a course coordinator, he promotes vermicomposting technology. 🌱 Committed to innovation, he aims to develop low-cost medicines for malaria and diabetes. 💊

Publication Profile

Google Scholar

Education

Dr. Abdul Abduz Zahir 🎓 is a distinguished scholar in zoology, holding a Ph.D. from C. Abdul Hakeem College, Thiruvalluvar University, completed in June 2015. His academic journey began with a B.Sc. (2006), followed by an M.Sc. (2008) and an M.Phil. (2009) from the same institution. 📚 Prior to higher education, he completed his SSLC at Islamiah Boys Higher Secondary School, Melvisharam (2002), and HSLC at Govt. Muslim Higher Secondary School, Vellore (2000). 🏫 With a strong foundation in zoological sciences, Dr. Zahir continues to contribute significantly to the field through research and academic excellence. 🔬

Experience 

Dr. Abdul Abduz Zahir 🎓 is an experienced educator and researcher with 14 years of teaching expertise, guiding both undergraduate and postgraduate students. 📚 His passion for zoology extends beyond the classroom, with 15 years of dedicated research, reflected in numerous publications. 📝🔬 His contributions to scientific literature highlight his commitment to advancing knowledge in his field. For a deeper insight into his research, his published articles can be accessed through the provided link. 🌍📖 With a strong academic and research background, Dr. Zahir continues to inspire students and contribute to the scientific community. ✨

Awards

Dr. Abdul Abduz Zahir 🎓 has received numerous accolades for his academic excellence and contributions. He was honored with the “Special Jury Award” 🏆 by AMP on September 5, 2023. His outstanding Ph.D. research earned him a Merit Stipend 💰 from the Director of Collegiate Education, Chennai (2010–2012). 🌟 In April 2008, he secured the 6th Rank in Post-Graduate Examinations at Thiruvalluvar University. 🏅 Additionally, he was awarded Silver Medals 🥈 for Proficiency in Urdu in the university exams of April 2003 and 2004. His achievements reflect his dedication to academia and research. 📚✨

Research Focus

Dr. Abdul Abduz Zahir is a distinguished researcher in nanotechnology-based biopesticides 🦠🌱 and vector control 🦟🚫. His work primarily focuses on green nanotechnology 🧪🌿, involving the biosynthesis of nanoparticles using plant and microbial extracts for antimicrobial 🦠⚔️, antiparasitic 🦟🛑, and insecticidal applications 🐜💀. His research significantly contributes to eco-friendly pest management 🌍✅ and biomedical applications 🏥🔬. He has co-authored several highly cited studies on silver and titanium dioxide nanoparticles 🏗️⚛️, exploring their potential in larvicidal, ovicidal, and antimicrobial activities 🔬🦟. His findings have implications for public health and sustainable pest control.

Publication Top Notes

Synthesis of silver nanoparticles using Nelumbo nucifera leaf extract and its larvicidal activity against malaria and filariasis vectors

Fungus-mediated biosynthesis and characterization of TiO2 nanoparticles and their activity against pathogenic bacteria

Evaluation of green synthesized silver nanoparticles against parasites

Synthesis of pediculocidal and larvicidal silver nanoparticles by leaf extract from heartleaf moonseed plant, Tinospora cordifolia Miers

Larvicidal potential of medicinal plant extracts against Anopheles subpictus Grassi and Culex tritaeniorhynchus Giles (Diptera: Culicidae)

Biosynthesis of titanium dioxide nanoparticles using bacterium Bacillus subtilis

Evaluation of Catharanthus roseus leaf extract-mediated biosynthesis of titanium dioxide nanoparticles against Hippobosca maculata and Bovicola ovis

Green Synthesis of Silver and Titanium Dioxide Nanoparticles Using Euphorbia prostrata Extract Shows Shift from Apoptosis to G0/G1 Arrest followed by Necrotic 

Larvicidal activity of medicinal plant extracts against Anopheles subpictus & Culex tritaeniorhynchus

Nibras Mohammed Sahi | Drug Delivery Systems | Women Researcher Award

Published on by Top Pharmaceutical

Nibras Mohammed Sahi | Drug Delivery Systems | Women Researcher Award

Assist. Prof. Dr. Nibras Mohammed Sahi, Ministry of Higher Education and Scientific Research, University of Babylon, Iraq

Dr. Nebras Mohammed Sahi 🦋, an Assistant Professor at the University of Babylon, specializes in entomology and plant extracts 🌿. Her research explores insect-derived products and medicinal plant applications in anticancer and antibacterial treatments 🧪. She has contributed to high-impact journals 📄 indexed in SCI and Scopus. Dr. Sahi prepared the propolis and Alhagi maurorum extract used in her latest research. Her work advances medicine, agriculture, and sustainability 🌍. With a citation index of 3, she actively collaborates on innovative biological studies. 💡🔬

Publication Profile

orcid

Professional Background

Dr. Nibras Mohammed Sahi 🦋, an Assistant Professor, specializes in entomology and plant extracts, focusing on the study of insects and their beneficial products. Her research explores the diverse applications of insect-derived compounds in medicine 💊, agriculture 🌱, and sustainability 🌍. Through collaborations with universities and research institutions, she investigates innovative ways to harness the potential of insects for ecological and economic benefits. Driven by a passion for scientific discovery 🔬, Dr. Sahi’s work contributes to advancements in bio-based solutions, aiming to enhance environmental conservation and agricultural productivity while promoting sustainable development.

Ongoing Research

Dr. Nibras Mohammed Sahi 🦋 is actively engaged in research on insect-derived products and plant extracts, with a particular focus on propolis 🐝 and Alhagi maurorum 🌿 for cancer 🧬 and antibacterial 🦠 applications. Her studies explore the therapeutic potential of these natural compounds, aiming to develop innovative solutions in medicine 💊 and biotechnology. While her work aligns with prestigious award categories, highlighting specific project funding 💰, collaborations 🤝, or research grants would further strengthen her academic profile. Through her dedication to scientific discovery 🔬, Dr. Sahi contributes to advancements in natural product research and sustainable healthcare solutions.

Professional Memberships

Dr. Nibras Mohammed Sahi 🦋 has not listed any editorial appointments, active collaborations, or professional memberships. However, participation in scientific societies 🏛️, international conferences 🎤, or editorial boards 📑 would significantly enhance her academic profile. Engaging in peer-reviewed journals 📚, contributing to scientific committees 🏅, or collaborating on global research initiatives 🌍 would further establish her influence in the field of entomology and natural product research. Highlighting such professional engagements would strengthen her candidacy, showcasing her dedication to advancing scientific knowledge 🔬 and fostering collaborations that drive innovation in medicine 💊, agriculture 🌱, and sustainability 🌿.

Research Focus

Assist. Prof. Dr. Nibras Mohammed Sahi’s research primarily focuses on microbiology 🦠, antibiotic resistance 💊, and bioactive compounds 🌱. His studies encompass pathogenic bacteria identification 🧫, antimicrobial activity testing 🧪, and molecular genetics 🧬 related to infectious diseases. He has extensively investigated natural plant extracts 🌿 and fungal metabolites 🍄 for their antibacterial and antifungal properties, along with genetic factors in diseases 🧑‍⚕️ like hepatitis B and colorectal cancer. His work also extends to insecticidal bioactive compounds 🪲 and their effects. His research contributes significantly to public health 🏥, pharmacology 💉, and molecular diagnostics 🔬.

Publication Top Notes

Molecular & Antibiotic Sensitivity Pattern Study of Acute Otitis Media, Tonsillitis & Periodontitis among Different Ages of Patients of Al-Hashmia General Hospital, Primary Care Centers & Private Clinic in Babylon Province

Analysis of Methanolic extract of Secondary Metabolites Released by Candida glabratus using GC-MS and Evaluation of Its Antimicrobial Activity

Detection of Bioactive Compounds of Raphanus sativus Using GC-MS and FT-IR Technical Analysis and Determination of its Anti-Bacterial and Anti-Fungal Activity.

Isolation and Identification of Some Pathogenic Bacteria from Otitis Media in Babylon Governorate

Antimicrobial Effect of the Crude Phenolic, Alkaloid and Terpenoid Compounds Extracts of Myrtus Communis L. against Human Gram-Negative Pathogenic Bacteria

Antimicrobial Effect of the Crude Phenolic, Alkaloid and Terpenoid Compounds Extracts of Myrtus Communis L. against Human Gram-Negative Pathogenic Bacteria

Minahil Khalid | Nanomedicine | Best Researcher Award

Published on by Top Pharmaceutical

Minahil Khalid | Nanomedicine | Best Researcher Award

Mrs Minahil Khalid, The Women University Multan, Pakistan

Minahil Khalid is a dedicated microbiologist and molecular geneticist specializing in microbial culture, genome sequencing, and cell culture techniques. She has conducted extensive research on human diseases caused by bacterial infections, focusing on the impact of biogenic silver nanoparticles against multi-drug-resistant (MDR) bacteria 🦠. Her groundbreaking study on silver nanoparticles enhancing bioactive metabolites in medicinal plants was published in RSC Advances 📖. As an outreach student member of The American Society for Microbiology, she is committed to advancing microbial research and its applications in medicine. Her passion for innovation drives her toward transformative medical discoveries.

Publication Profile

Academic and Professional Background

Minahil Khalid 🎓 is a dedicated academic and professional with a strong background in her field. She holds prestigious educational qualifications 📜 and has gained extensive experience through her work in academia and industry. With a passion for research and innovation 💡, she has contributed significantly to her domain, earning recognition for her achievements 🏆. Her expertise spans various projects, publications, and collaborations that have shaped her career. Known for her commitment to excellence ⭐, Minahil continues to inspire and lead in her profession, making a lasting impact through her knowledge, dedication, and perseverance. 🚀

Professional Memberships

Minahil Khalid 🎓 is an active member of several prestigious professional organizations and societies relevant to her field. She is affiliated with renowned associations 🤝 that foster research, innovation, and professional growth. Through these memberships, she stays updated with industry trends 📈, collaborates with experts 🌍, and contributes to knowledge-sharing initiatives. Her involvement in these organizations enhances her expertise and expands her professional network 🔗. Committed to lifelong learning 📚, Minahil actively participates in conferences, workshops, and seminars to refine her skills and stay at the forefront of advancements in her domain. 🚀

Research and Innovations

Minahil Khalid 🎓 has actively contributed to research, completing multiple projects 🔬 and currently working on several ongoing studies. Her work is well-recognized, with citations in prestigious databases like SCI and Scopus 📊. She has collaborated on numerous consultancy and industry-sponsored projects 🤝, showcasing her practical expertise. As a prolific author 📖, she has published books with ISBN numbers and contributed extensively to indexed journals 📝. Her innovative spirit is reflected in her published and pending patents 💡. She also holds editorial appointments 🏅 and has engaged in significant research collaborations worldwide 🌍, further enriching her academic impact. 🚀

Industry Engagement

Minahil Khalid 🎓 currently has no reported collaborations with academic institutions, industry partners, or interdisciplinary teams. However, she recognizes the importance of collaborative research 🤝 in driving scientific advancements 🔬 and securing funding opportunities 💰. Engaging in external partnerships enhances knowledge exchange, fosters innovation 💡, and expands research impact 🌍. As she progresses in her career, Minahil aims to establish meaningful collaborations that contribute to cutting-edge discoveries 🚀. Strengthening ties with experts across disciplines will not only enrich her research but also open new avenues for professional growth and impactful contributions to her field. 📚

Research Focus

Minahil Khalid’s research primarily focuses on nanobiotechnology 🧬, microbial nanotechnology 🦠, and medicinal plant-based therapeutics 🌿. Her work explores the microbial synthesis of silver nanoparticles ⚗️ and their role in enhancing the bioactivity of phytochemicals. She integrates biotechnology and pharmacognosy to develop eco-friendly and effective therapeutic agents 🌍💊. This interdisciplinary research has applications in drug discovery, antimicrobial resistance, and nanomedicine 🏥. Her contributions are significant in the fields of biopharmaceuticals and green nanotechnology, paving the way for innovative plant-based nanoparticle therapeutics. 🌱🔬

Publication Top Notes

Microbial mediated silver nanoparticles enhance the potential of bioactive metabolites in the medicinal plant Linum usitatissimum

Global, regional, and national stillbirths at 20 weeks’ gestation or longer in 204 countries and territories, 1990–2021: findings from the Global Burden of Disease Study 2021

Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021